{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:13:22Z","timestamp":1792602802509,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","award":["ARS01_00345"],"award-info":[{"award-number":["ARS01_00345"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejmech.2021.113737","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T05:28:40Z","timestamp":1627968520000},"page":"113737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8483-1885","authenticated-orcid":false,"given":"Letizia","family":"Giampietro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2283-4159","authenticated-orcid":false,"given":"Marialucia","family":"Gallorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4369-1772","authenticated-orcid":false,"given":"Alessandra","family":"Ammazzalorso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Della Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2401-7547","authenticated-orcid":false,"given":"Marialuigia","family":"Fantacuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-8650","authenticated-orcid":false,"given":"Cristina","family":"Maccallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4989-6210","authenticated-orcid":false,"given":"Amelia","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Nicolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8282-8535","authenticated-orcid":false,"given":"Rosa","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113737_bib1","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis\u2217","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejmech.2021.113737_bib2","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1021\/acs.jmedchem.5b01281","article-title":"Recent progress in the discovery of next generation inhibitors of aromatase from the structure-function perspective","volume":"59","author":"Ghosh","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1210\/er.2004-0015","article-title":"Aromatase inhibitors in the treatment of breast cancer","volume":"26","author":"Brueggemeier","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejmech.2021.113737_bib4","doi-asserted-by":"crossref","first-page":"21399","DOI":"10.1016\/S0021-9258(19)36937-6","article-title":"Core glycosylation of cytochrome P-450(arom). Evidence for localization of N terminus of microsomal cytochrome P-450 in the lumen","volume":"268","author":"Shimozawa","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib5","series-title":"Ligand- and Structure-Based Drug Design of Non-steroidal Aromatase Inhibitors (NSAIs) in Breast Cancer","first-page":"400","author":"Jha","year":"2015"},{"key":"10.1016\/j.ejmech.2021.113737_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsbmb.2015.07.018","article-title":"Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and \u2013resistant breast cancer cells","volume":"161","author":"Chan","year":"2016","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113737_bib7","first-page":"5386193","article-title":"A\u00a0review on sex steroid hormone estrogen receptors in mammals and fish","volume":"2020","author":"Amenyogbe","year":"2020","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.ejmech.2021.113737_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1152\/physiol.00054.2015","article-title":"Aromatase: contributions to physiology and disease in women and men","volume":"31","author":"Blakemore","year":"2016","journal-title":"Physiology"},{"key":"10.1016\/j.ejmech.2021.113737_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jsbmb.2019.03.002","article-title":"Estrogens and breast cancer: mechanisms involved in obesity-related development, growth and progression","volume":"189","author":"Bhardwaj","year":"2019","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113737_bib10","doi-asserted-by":"crossref","first-page":"112845","DOI":"10.1016\/j.ejmech.2020.112845","article-title":"Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: comparative SAR\/QSAR assessment on steroidal aromatase inhibitors","volume":"208","author":"Adhikari","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib11","series-title":"in: Treasure Island (FL)","article-title":"Aromatase inhibitors","author":"Peters","year":"2021"},{"key":"10.1016\/j.ejmech.2021.113737_bib12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1210\/endo-92-3-866","article-title":"Studies on the mechanism of estrogen biosynthesis. 8. The development of inhibitors of the enzyme system in human placenta","volume":"92","author":"Schwarzel","year":"1973","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2021.113737_bib13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm00208a002","article-title":"Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis","volume":"21","author":"Brueggemeier","year":"1978","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165625","article-title":"Aromatase inhibitors-induced musculoskeletal disorders: current knowledge on clinical and molecular aspects","volume":"21","author":"Tenti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113737_bib15","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A\u00a0comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113737_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1759720X18759291","article-title":"Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis","volume":"10","author":"Tseng","year":"2018","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.ejmech.2021.113737_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/annonc\/mdw673","article-title":"Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Khosrow-Khavar","year":"2017","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.ejmech.2021.113737_bib18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/cmdc.201700045","article-title":"Anticancer activity of stilbene-based derivatives","volume":"12","author":"De Filippis","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113737_bib19","article-title":"More than resveratrol: new insights into stilbene-based compounds","volume":"10","author":"Pecyna","year":"2020","journal-title":"Biomol"},{"key":"10.1016\/j.ejmech.2021.113737_bib20","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/med.21536","article-title":"Polyphenolic natural products and natural product-inspired steroidal mimics as aromatase inhibitors","volume":"39","author":"Nielsen","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113737_bib21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/mnfr.201100122","article-title":"Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity","volume":"55","author":"Kondratyuk","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejmech.2021.113737_bib22","doi-asserted-by":"crossref","first-page":"112356","DOI":"10.1016\/j.ejmech.2020.112356","article-title":"Resveratrol - a comprehensive review of recent advances in anticancer drug design and development","volume":"200","author":"Ahmadi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00044-019-02351-3","article-title":"Synthesis and cytotoxic effects on pancreatic cancer cellsof resveratrol analogs","volume":"28","author":"De Filippis","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113737_bib24","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.bmcl.2019.03.033","article-title":"Synthesis of \u03b1-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors","volume":"29","author":"Nielsen","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113737_bib25","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1016\/j.bmc.2010.05.042","article-title":"Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer","volume":"18","author":"Sun","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/0929867053363540","article-title":"Bioisosterism: a useful strategy for molecular modification and drug design","volume":"12","author":"Lima","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib27","article-title":"\u03c0-\u03c0 conjugation enhances oligostilbene's antioxidant capacity: evidence from \u03b1-viniferin and caraphenol A","volume":"23","author":"Li","year":"2018","journal-title":"Mol"},{"key":"10.1016\/j.ejmech.2021.113737_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030605","article-title":"Aza- and azo-stilbenes: bio-isosteric analogs of resveratrol","volume":"25","author":"Lizard","year":"2020","journal-title":"Mol"},{"key":"10.1016\/j.ejmech.2021.113737_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1021\/acsmedchemlett.8b00574","article-title":"Novel phenyldiazenyl fibrate analogues as PPAR \u03b1\/\u03b3\/\u03b4 pan-agonists for the amelioration of metabolic syndrome","volume":"10","author":"Giampietro","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113737_bib30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/1385272822666180122153839","article-title":"Sulfonamides as potential bioactive scaffolds","volume":"22","author":"Khan","year":"2018","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib31","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/cbdd.13043","article-title":"Synthetic routes and biological potential in medicinal chemistry","volume":"90","author":"Ammazzalorso","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.113737_bib32","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1016\/j.bmc.2015.04.036","article-title":"Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors","volume":"23","author":"Pingaew","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ejmech.2016.10.020","article-title":"Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers","volume":"124","author":"Ghorab","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib34","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ejmech.2017.10.057","article-title":"Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors","volume":"143","author":"Pingaew","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejmech.2017.04.028","article-title":"Aromatase inhibitors and apoptotic inducers: design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules","volume":"134","author":"Ghorab","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib36","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1021\/jm2000689","article-title":"Structure-based design of potent aromatase inhibitors by high-throughput docking","volume":"54","author":"Caporuscio","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib37","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.bmcl.2016.04.078","article-title":"Synthesis and biological characterization of 3-(imidazole-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors","volume":"26","author":"Di Matteo","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113737_bib38","doi-asserted-by":"crossref","first-page":"111815","DOI":"10.1016\/j.ejmech.2019.111815","article-title":"Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors","volume":"185","author":"Fantacuzzi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib39","doi-asserted-by":"crossref","first-page":"113115","DOI":"10.1016\/j.ejmech.2020.113115","article-title":"Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors","volume":"211","author":"Ammazzalorso","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-62703-290-2_7","article-title":"Detection of necrosis by release of lactate dehydrogenase activity","volume":"979","author":"Chan","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113737_bib41","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s10495-013-0879-6","article-title":"Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis","volume":"18","author":"Amaral","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2021.113737_bib42","first-page":"3392","article-title":"Genome-wide analysis of the three-way interplay among gene expression, estrogen receptor expression and chemotherapeutic sensitivity in breast cancer","volume":"38","author":"He","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2021.113737_bib43","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/153537020322800903","article-title":"Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system","volume":"228","author":"Simstein","year":"2003","journal-title":"Exp. Biol. Med."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113737_bib44","doi-asserted-by":"crossref","first-page":"884s","DOI":"10.1158\/1078-0432.884s.11.2","article-title":"Therapeutic observations in MCF-7 aromatase xenografts","volume":"15","author":"Brodie","year":"2005","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113737_bib45","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.3390\/ijms21165841","article-title":"Evidence for enhanced exosome production in aromatase inhibitor-resistant breast cancer cells","volume":"21","author":"Augimeri","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113737_bib46","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1080\/14756366.2020.1780228","article-title":"Synthesis and evaluation of a large library ofnitroxoline derivatives as pancreatic cancerantiproliferative agents","volume":"35","author":"Veschi","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib47","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2021.113737_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature07614","article-title":"Structural basis for androgen specificity and oestrogen synthesis in human aromatase","volume":"457","author":"Ghosh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113737_bib49","series-title":"Schr\u00f6dinger Release 2020-4: Protein Preparation Wizard","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113737_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2021.113737_bib51","series-title":"Schr\u00f6dinger Release 2020-4","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113737_bib52","series-title":"Schr\u00f6dinger Release 2020-4: Induced Fit Docking Protocol; Glide","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113737_bib53","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib54","series-title":"Schr\u00f6dinger Release 2020-4: Prime","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113737_bib55","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113737_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2021.113737_bib57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:37:21Z","timestamp":1759329441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421005869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":57,"alternative-id":["S0223523421005869"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113737","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113737"}}